HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anais Vallet-Pichard Selected Research

Antiviral Agents (Antivirals)

1/2021Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort.
1/2018Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.
7/2014Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal.
9/2013Hepatitis C virus infection in hemodialysis patients.
7/2012Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection.
8/2011Viral hepatitis in solid organ transplantation other than liver.
6/2009Treatment of HBV-related cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anais Vallet-Pichard Research Topics

Disease

7Fibrosis (Cirrhosis)
07/2014 - 09/2004
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 06/2009
4Infections
01/2018 - 03/2004
4Liver Cirrhosis (Hepatic Cirrhosis)
07/2014 - 12/2005
3Liver Diseases (Liver Disease)
04/2024 - 03/2004
2Hepatitis
08/2011 - 03/2004
2Chronic Hepatitis C
12/2005 - 09/2004
2Hepatitis C
09/2004 - 03/2004
1Neoplasms (Cancer)
01/2021
1Chronic Renal Insufficiency
01/2018
1Disease Progression
07/2014
1Chronic Hepatitis B
07/2012
1Chronic Hepatitis (Chronic Active Hepatitis)
08/2011
1End Stage Liver Disease
06/2009
1Non-alcoholic Fatty Liver Disease
03/2004
1Hyperlipidemias (Hyperlipidemia)
03/2004
1Hepatitis B
03/2004
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2004
1Overweight
03/2004
1HIV Infections (HIV Infection)
03/2004

Drug/Important Bio-Agent (IBA)

7Antiviral Agents (Antivirals)IBA
01/2021 - 06/2009
2InterferonsIBA
07/2014 - 06/2009
2entecavirFDA Link
07/2014 - 08/2011
2Tenofovir (Viread)FDA Link
07/2014 - 08/2011
2NucleosidesIBA
08/2011 - 06/2009
2NucleotidesIBA
08/2011 - 06/2009
1elbasvirIBA
01/2018
1grazoprevirIBA
01/2018
1Hepatitis B e AntigensIBA
07/2014
1DNA (Deoxyribonucleic Acid)IBA
07/2014
1Hepatitis B Surface Antigens (HBsAg)FDA Link
07/2014
1ErythropoietinFDA Link
08/2011
1Lamivudine (Epivir)FDA Link
08/2011
1Ribavirin (Virazole)FDA LinkGeneric
09/2004
1EnzymesIBA
03/2004
1Illicit Drugs (Recreational Drugs)IBA
03/2004
1Methamphetamine (Desoxyn)FDA LinkGeneric
03/2004

Therapy/Procedure

6Therapeutics
04/2024 - 06/2009
3Renal Dialysis (Hemodialysis)
01/2018 - 12/2005
2Transplantation
09/2013 - 08/2011
2Contraindications
09/2013 - 08/2011
2Kidney Transplantation
09/2013 - 08/2011
1Organ Transplantation
08/2011
1Highly Active Antiretroviral Therapy (HAART)
03/2004